Acadian Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Hold |
179,614
| – | – | ﹤0.01% | 1235 |
|
|
2026
Q1 | $873K | Buy |
179,614
+2,351
| +1% | +$13.1K | ﹤0.01% | 1203 |
|
|
2025
Q4 | $1.18M | Buy |
177,263
+70,294
| +66% | +$417K | ﹤0.01% | 1068 |
|
|
2025
Q3 | $467K | Buy |
106,969
+3,046
| +3% | +$14.5K | ﹤0.01% | 1240 |
|
|
2025
Q2 | $459K | Sell |
103,923
-3,784
| -4% | -$15.8K | ﹤0.01% | 1158 |
|
|
2025
Q1 | $606K | Buy |
107,707
+7,828
| +8% | +$100K | ﹤0.01% | 1047 |
|
|
2024
Q4 | $2.1M | Buy |
99,879
+12,518
| +14% | +$288K | 0.01% | 753 |
|
|
2024
Q3 | $2.35M | Sell |
87,361
-8,950
| -9% | -$264K | 0.01% | 701 |
|
|
2024
Q2 | $2.74M | Sell |
96,311
-4,099
| -4% | -$144K | 0.01% | 677 |
|
|
2024
Q1 | $4.25M | Sell |
100,410
-575
| -0.6% | -$25.9K | 0.01% | 512 |
|
|
2023
Q4 | $5.4M | Sell |
100,985
-5,401
| -5% | -$244K | 0.02% | 428 |
|
|
2023
Q3 | $4.57M | Sell |
106,386
-4,139
| -4% | -$191K | 0.02% | 461 |
|
|
2023
Q2 | $6.07M | Hold |
110,525
| – | – | 0.02% | 402 |
|
|
2023
Q1 | $4.64M | Hold |
110,525
| – | – | 0.02% | 473 |
|
|
2022
Q4 | $3.06M | Buy |
110,525
+2,687
| +2% | +$66.2K | 0.02% | 566 |
|
|
2022
Q3 | $2.76M | Buy |
107,838
+2,955
| +3% | +$97.8K | 0.02% | 544 |
|
|
2022
Q2 | $3.78M | Sell |
104,883
-1,848
| -2% | -$83.4K | 0.02% | 480 |
|
|
2022
Q1 | $6.63M | Sell |
106,731
-7,060
| -6% | -$418K | 0.03% | 400 |
|
|
2021
Q4 | $8.02M | Sell |
113,791
-542
| -0.5% | -$38.5K | 0.03% | 351 |
|
|
2021
Q3 | $7.98M | Buy |
114,333
+6,767
| +6% | +$539K | 0.03% | 351 |
|
|
2021
Q2 | $8.96M | Buy |
107,566
+5,579
| +5% | +$395K | 0.03% | 334 |
|
|
2021
Q1 | $5.57M | Sell |
101,987
-7,677
| -7% | -$373K | 0.02% | 446 |
|
|
2020
Q4 | $4.7M | Buy |
109,664
+680
| +0.6% | +$25.4K | 0.02% | 513 |
|
|
2020
Q3 | $3.28M | Sell |
108,984
-1,154
| -1% | -$38.8K | 0.01% | 528 |
|
|
2020
Q2 | $3.41M | Buy |
110,138
+2,942
| +3% | +$79.3K | 0.01% | 571 |
|
|
2020
Q1 | $2.37M | Buy |
107,196
+1,149
| +1% | +$31.1K | 0.01% | 552 |
|
|
2019
Q4 | $3.23M | Sell |
106,047
-2,130
| -2% | -$61.3K | 0.01% | 548 |
|
|
2019
Q3 | $3.33M | Buy |
108,177
+2,974
| +3% | +$73.9K | 0.01% | 550 |
|
|
2019
Q2 | $2.1M | Buy |
105,203
+28,129
| +36% | +$824K | 0.01% | 610 |
|
|
2019
Q1 | $3.32M | Sell |
77,074
-3,821
| -5% | -$139K | 0.01% | 547 |
|
|
2018
Q4 | $2.57M | Sell |
80,895
-4,565
| -5% | -$180K | 0.01% | 518 |
|
|
2018
Q3 | $4.48M | Buy |
85,460
+170
| +0.2% | +$9.54K | 0.02% | 399 |
|
|
2018
Q2 | $4.56M | Buy |
85,290
+489
| +0.6% | +$25K | 0.02% | 404 |
|
|
2018
Q1 | $4.24M | Buy |
84,801
+14,147
| +20% | +$634K | 0.02% | 435 |
|
|
2017
Q4 | $2.33M | Sell |
70,654
-322
| -0.5% | -$10.9K | 0.01% | 527 |
|
|
2017
Q3 | $2.67M | Sell |
70,976
-2,581
| -4% | -$76.3K | 0.01% | 499 |
|
|
2017
Q2 | $1.88M | Sell |
73,557
-316
| -0.4% | -$7.82K | 0.01% | 583 |
|
|
2017
Q1 | $1.92M | Sell |
73,873
-2,301
| -3% | -$66.3K | 0.01% | 629 |
|
|
2016
Q4 | $2.32M | Hold |
76,174
| – | – | 0.01% | 561 |
|
|
2016
Q3 | $2.07M | Buy |
76,174
+3,196
| +4% | +$88.7K | 0.01% | 531 |
|
|
2016
Q2 | $2.09M | Buy |
72,978
+2,196
| +3% | +$69.8K | 0.01% | 513 |
|
|
2016
Q1 | $2.14M | Buy |
70,782
+1,503
| +2% | +$42.6K | 0.01% | 528 |
|
|
2015
Q4 | $2.4M | Sell |
69,279
-2,097
| -3% | -$71.7K | 0.01% | 544 |
|
|
2015
Q3 | $2.7M | Sell |
71,376
-16,519
| -19% | -$769K | 0.01% | 497 |
|
|
2015
Q2 | $5.01M | Sell |
87,895
-198
| -0.2% | -$11.3K | 0.02% | 408 |
|
|
2015
Q1 | $5.13M | Buy |
88,093
+910
| +1% | +$48.9K | 0.02% | 391 |
|
|
2014
Q4 | $4.95M | Hold |
87,183
| – | – | 0.02% | 404 |
|
|
2014
Q3 | $3.56M | Buy |
87,183
+40,287
| +86% | +$1.85M | 0.02% | 411 |
|
|
2014
Q2 | $2.14M | Buy |
46,896
+36,089
| +334% | +$1.52M | 0.01% | 489 |
|
|
2014
Q1 | $512K | Buy |
10,807
+1,859
| +21% | +$84.6K | ﹤0.01% | 668 |
|
|
2013
Q4 | $421K | Sell |
8,948
-5,245
| -37% | -$229K | ﹤0.01% | 717 |
|
|
2013
Q3 | $566K | Sell |
14,193
-12,372
| -47% | -$487K | ﹤0.01% | 614 |
|
|
2013
Q2 | $947K | Buy |
+26,565
| New | +$1.02M | 0.01% | 497 |
|
Other funds holding HBIO
WCM
MIM
NCNMGF
CCM
MBAM
Acadian Asset Management's HBIO Position: Q2 2026 in Review
Acadian Asset Management held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 179,614 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1235.
Acadian Asset Management first reported a position in HBIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.96M in Q2 2021. 34 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.
- Acadian Asset Management held 179,614 shares of Harvard Bioscience worth $1.1M as of Q2 2026.
- Acadian Asset Management left its Harvard Bioscience share count unchanged in Q2 2026.
- Harvard Bioscience made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1235 holding.
- Acadian Asset Management first reported a position in Harvard Bioscience in Q2 2013 and has held it in 53 quarters since.
- Acadian Asset Management's Harvard Bioscience position peaked at $8.96M in Q2 2021.
- 34 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.